Protein with xylanase activity
A mutated recombinant xylanase with specific mutations addresses the issues of thermostability and production, maintaining high activity at 80°C and supporting efficient industrial use.
Patent Information
- Application Number
- FR2022000999
- Authority / Receiving Office
- FR · FR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-02-04
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2042-02-04
AI Technical Summary
Existing xylanases of natural origin are not thermostable and lose activity at high temperatures, such as those encountered in animal digestion and food processing, and their industrial production is challenging.
A mutated recombinant xylanase with specific mutations (L34C and R38C) and optionally additional mutations (T112E, Q145E, S187R) is developed, enhancing thermostability and maintaining high xylanase activity even after exposure to 80°C, while maintaining production yields.
The mutated xylanase retains twice the activity after 50 minutes at 80°C compared to natural xylanases and maintains activity in animal digestive conditions, with improved production efficiency.
Smart Images

Figure 00000012_0000 
Figure 00000012_0001 
Figure 00000013_0000
Abstract
Description
Title of the invention: Protein with xylanase activity
[0001] The present invention relates to a protein having at least one xylanase activity.
[0002] By xylanase activity, according to the invention is meant a protein or an enzyme, of natural or modified origin, capable of promoting the degradation, at least partial, of xylan, by hydrolysis, by releasing xylose or an intermediate molecule capable of being transformed into xylose by another enzyme, under determined conditions. Several enzymes, or xylanases, corresponding to this definition are known, which differ by their specific mode of action of certain chemical bonds, among which endoxylanase or endo-1,4-[3-xylanase and beta-xylosidase.
[0003] Xylan is a so-called non-starch polysaccharide (NSP) abundant in nature; it is a major constituent of hemicellulose. It is widely present in human and animal food due to diets that may be rich in plant fibers. However, neither humans nor mammals are capable of producing xylanase, or at least not in sufficient quantity for effective hydrolysis, and an addition of xylanase to the diet may be desirable to promote the digestion of carbohydrates. Thus, xylanase supplementation is widely used in animal nutrition, particularly for livestock, in order to optimize the use of the fiber portion of the feed by the animal, resulting in an increase in growth performance. This is referred to as a zootechnical additive.
[0004] Since the action of a xylanase is specific, a mixture of xylanases with preferably complementary mechanisms is advantageously used. A xylanase or a mixture of xylanases is (are) also generally used in combination with one or more other enzymes in order to degrade other polysaccharides present in the food, such as a beta-glucanase, an amylase, a protease or in order to confer an additional benefit to the additive, such as a phytase.
[0005] Xylanases can be produced naturally by many organisms such as plants, algae, gastropods, arthropods, yeasts, fungi, bacteria, protozoa; however, they have been the subject of numerous studies to improve their properties and the industry mainly uses proteins produced by genetically modified organisms.
[0006] If, in the present text, the interest of a xylanase according to the invention is illustrated in an application to animal nutrition, the invention is not limited thereto and the vocation of such a xylanase may be quite different, for example in the fields of waste treatment, the pulp and paper industry, textiles, the production of biofuels, the agri-food industry as in breadmaking.
[0007] As a zootechnical additive, xylanase or the mixture of enzymes containing it must withstand the conditions, particularly thermal, of the environment in which it is used, namely those of the animal's digestive system, the temperature of which can vary from approximately 35°C to 42°C, or even higher. Furthermore, the xylanase or the mixture of enzymes containing it is mixed with the feed and therefore subjected to a transformation process for its shaping, including stages of mechanical treatment and heat treatment. The use of heat to shape the feed can reach temperatures of around 80°C or more, and it is essential that the enzyme(s) are not denatured by such treatment to preserve their hydrolytic potential and therefore their benefit (J. Inborr et al. Animal Feed Science and Technology: Stability of feed enzymes to steam pelleting during feed processing, 46 (1994) pp. 179-196).While naturally occurring xylanase is not affected by temperatures up to 50°C, this is no longer the case at higher temperatures, and its activity can drop drastically. Indeed, exposure to such temperatures causes irreversible changes in the enzyme, particularly through the destruction of intramolecular bonds in the tertiary or quaternary protein structures, inhibiting the enzyme's activity.
[0008] We are therefore looking for enzymes with xylanase activity, which are thermostable, capable of withstanding the heat treatments applied to them and which have a xylanase activity greater than that of the natural enzyme exposed to the same conditions.
[0009] The development of a thermostable xylanase that can be used on an industrial scale as well as in the field of animal nutrition nevertheless faces another obstacle, that of profitable production.
[0010] The document Zhe Xu et al., Recent advances in the improvement of enzyme thermo-stability by structure modification, 2020, vol. 40, no. 1 pp 83-98, reports the latest developments in the development of thermostable enzymes in relation to their secondary and tertiary structure. Mutations are made to generate covalent and non-covalent interactions likely to give the enzyme greater thermostability. If a relationship does indeed exist between molecular structure and thermostability, improving the thermostability of an enzyme remains a difficulty despite the tools of protein engineering.
[0011] The invention provides a mutated xylanase which is a good compromise between thermostability and industrial production. Indeed, after exposure to temperatures of the order of 80°C, the enzyme of the invention retains a strong xylanase activity, under the environmental conditions to which it is subjected in the digestive system of an animal, such as an acid pH, a temperature of approximately 35°C to 42°C, while being able to be produced in yields of the order of those of the natural enzyme.
[0012] The starting point of the invention is a recombinant xylanase EvAus Xynl IA having greater thermostability than the xylanases of family 11 of naturally produced glycoside hydrolases (GH) which is described in document CN102492676A. EvAus Xynl IA is obtained from the xylanase Aus Xynl 1 whose N-terminal sequence has been substituted by that of EvXynATS and is identified by the peptide sequence SEQ ID NO: 1 and named XYN3, in the present text.
[0013] One or more specific mutations have been introduced into the peptide sequence of this protein, resulting in an unexpected increase in the thermostability of the xylanase.
[0014] Specifically, the invention relates to a thermostable protein expressing at least one xylanase activity, said protein comprising or consisting of a peptide sequence represented by SEQ ID NO: 1 comprising at least the mutations L34C and R38C.
[0015] As shown by the results presented later in the text, these mutations result, after 50 minutes of exposure to 80°C, in more than a doubling of the xylanase activity of the XYN3 protein measured at 50°C.
[0016] It has further been discovered that complementary mutations can contribute to an increase in the production yield of the protein and / or an improvement in its thermostability. Thus, the invention relates to a thermostable protein expressing at least one xylanase activity, said protein comprising or consisting of a peptide sequence represented by SEQ ID NO: 1 which comprises at least the mutations L34C and R38C and one or more mutations chosen from T112E, Q145E, S187R. The presence of one of these complementary mutations, or even two and even three, leads to a highly thermostable protein without significantly affecting its production yield.
[0017] The invention also relates to a polynucleotide coding for a protein of the invention as defined above.
[0018] By polynucleotide coding for a protein, we mean a sequence of nucleic acid(s) of DNA, cDNA, or synthetic DNA which corresponds to the open reading frame (ORF) which is translated into said protein, in particular, it may comprise a start codon and a stop codon. It may also comprise any additional nucleic sequence necessary for the expression of said protein; these will in particular be regulatory sequences including at least one or more promoters and signals for starting and stopping transcription or translation. It is of course within the general knowledge of those skilled in the art to use all the tools, methods and techniques to which they have access in this field of biology.
[0019] Thus, a polynucleotide of the invention comprises or consists of a nucleotide sequence SEQ ID No: 2 having at each of positions 100-102 and 112-114, the codon TGT or TGC coding for cysteine, to take into account the degeneracy of the genetic code. Another polynucleotide of the invention comprises or consists of SEQ ID NO: 2 having at each of positions 100-102 and 112-114, the codon TGT or TGC coding for cysteine, and furthermore having at least one of the following mutations, or any two of the following mutations, or even all three of the following mutations:
[0020] at position 334-336, the GAA or GAG codon coding for glutamic acid,
[0021] at position 433-435, the GAA or GAG codon coding for glutamic acid,
[0022] at position 559-561, the codon CGT, CGC, CGA, CGG, AGA,AGG coding for arginine.
[0023] It is of course within the general knowledge of those skilled in the art to deduce from a protein of the invention the nucleotide sequence of the corresponding reading frame.
[0024] Yet another subject of the invention is an expression vector such as a plasmid, comprising a polynucleotide of the invention, and at least the elements necessary for its expression in a host cell.
[0025] The invention also relates to a host cell comprising a aforementioned expression vector.
[0026] As stated above, a protein of the invention finds application, without being limited thereto, in food and in particular in animal nutrition. In this regard, the invention relates to a zootechnical additive comprising at least one such protein, and also to a feed for animal nutrition comprising at least one such zootechnical additive. A preferred target is monogastric livestock.
[0027] Thus, any use of a protein of the invention for feeding animals, for example livestock animals and in particular monogastric livestock animals, or for preparing a zootechnical additive as defined above or a food as defined above is part of the invention.
[0028] The invention also relates to a method for manufacturing a protein of the invention, comprising at least one step of culturing a host cell defined above under conditions suitable for the production of said protein and a step of recovering said protein.
[0029] The invention is illustrated in the following examples with the support of the figures according to which:
[0030] [Fig. 1] represents the thermostability of the XYN321 variant compared to the reference XYN3 protein;
[0031] [Fig.2] represents the thermostability of the XYN321, XYN328 and XYN320 variants compared to the reference XYN3 protein;
[0032] [Fig.3] represents the thermostability of the XYN321, XYN326 and XYN327 variant compared to the reference XYN3 protein;
[0033] [Fig.4] illustrates the thermostability of the XYN321 variant compared to the reference XYN3 protein during the manufacture of a food according to the invention. Example 1: Production of XYN3 variants
[0034] The variants were obtained by conventional recombinant DNA technology implementing the steps of providing a nucleic acid sequence coding for the protein of interest, inserting said sequence into an expression vector and introducing said vector into an appropriate cellular system allowing the recombinant protein to be produced by culture.
[0035] The genes encoding the variants were obtained by chemical synthesis of the nucleotide sequences.
[0036] These technologies are entirely within the general knowledge of those skilled in the art. For all useful purposes, reference may be made to AL Demain et al., Bio-technology Advances, Production of Recombinant Proteins by Microbes and Higher Organisms, 27 2009, pp 297-306 for the production of proteins, and to RA Hugues et al., Methods in Enzymology, Volume 498, 2011, Elsevier Inc. Gene Synthesis: Methods and Applications, Chapter 12, pp 277-309 for the synthesis of genes involved in the production of variants.
[0037] The variants listed in Table 1 below were manufactured.
[0038] [Tableauxl] Protein Mutations on SEQ ID NO: 1 L34C / R38 C T112E Q145E S187R T179C / S188C XYN3 (reference) - - - - - XYN321 X - - - - XYN320 X - - X - XYN328 XX - - - XYN326 XXX - - XYN327 XX - X - XYN383 (not disclosed) - X - - - XYN384 (not disclosed) - - X - - XYN386 (not disclosed) - - - X - XYN376 (not disclosed) - XX XYN380 (not disclosed) XX XYN374 (not disclosed) - XXX XYN388 (not disclosed) - XXXX
[0039] Example 2: Influence of the mutation(s) on the production of the protein, on its xvlanase activity and on its thermostability
[0040] 2.1-Influence on production:
[0041] The production of each of the variants listed in Table 1 is evaluated on the basis of the enzymatic activity assayed according to the DNS method. This method consists of incubating a solution containing the variant in the presence of beech xylan for 10 minutes at 50°C. The xylanase cuts the xylan chain (composed of xyloses) into shorter chains or oligosaccharides and thus releases reducing ends or reducing xyloses. These are assayed by dinitrosalicylic acid (DNS) at 95°C and at alkaline pH, the DNS binds to the reducing oses revealing a yellow color. orange proportional to the quantity of reduced oses and measurable with a spectrophotometer at 540 nm. Each measurement is carried out in duplicate. Quantification is carried out using a standard range of xylose, a reducing sugar.
[0042] 2.2-Influence on xylanase activity after incubation at 80°C
[0043] Thermal stability was studied in vitro by incubating culture supernatants containing a sufficient amount of each enzyme at 80°C and measuring their activity, after incubation for 0, 5, 10, 20, 30, 40, 50 and 60 minutes at 80°C. Immediately after incubation at 80°C, the samples were placed in ice (+4°C) and then centrifuged to bring all the supernatant to the bottom of the tube. The supernatant was then diluted in 25mM sodium acetate buffer pH 4.0 + 0.1% BSA so as to obtain a concentration of xylanase suitable for the DNS assay. The xylanase activity was then measured by DNS for each incubation time.
[0044] The results of xylanase production and activity at 80°C are shown in [Table 2] below.
[0045] [Tables2] Protein Production U.mL 1% Initial activity after 50 min at 80°C XYN3 (reference) 18 30 XYN321 13 69 XYN320 9 80 XYN328 14 73 XYN326 7 86 XYN327 13 90 XYN383 (not in the invention) 7 5 XYN384 (not in the invention) 10 5 XYN386 (not in the invention) 12 6 XYN376 (not in the invention) 16 19 XYN380 (not in the invention) 11 18 XYN374 (not in the invention) 11 50 XYN388 (not in the invention) 13 46
[0046] In support of [Table 2] and the figures, the following phenomena are observed:
[0047] - [Fig.l]: the L34C and R38C (XYN321) mutations generating a disulfide bridge make it possible to considerably increase the stability of the xylanase: the residual activity after 50 minutes of incubation at 80°C is 71% on average compared to 31% for the native protein. Even if they lead to a slight decrease in the production of the XYN321 enzyme of the XYN-3 enzyme expressed under the control of the same promoters, this is insignificant compared to the thermostability conferred on the protein; - [Fig.2]: the combination of mutations L34C and R38C (XYN321) generating a disulfide bridge with a Tl 12E or S187R mutation generating a salt bridge results in an increase in protein stability of 10%; - [Fig.3]: the combination of the L34C and R38C (XYN321) mutations generating a disulfide bridge with the Tl 12E mutation generating a first salt bridge and either of the Q145E and S187R mutations generating a second salt bridge results in an increase in protein stability of 25%.
[0048] Example 3: Influence of the mutation(s) of a xylanase according to the invention on its enzymatic activity measured on a food sample (in vivo test) Preparation of a food according to the invention
[0049] A suitable method is described in document WO2009 / 019335A1.
[0050] Manufacture of enzyme particles
[0051] The enzyme in liquid form is deposited on a support consisting of flour (or any other suitable support) by spray-drying, involving spraying the enzyme onto the flour and co-drying, for example by atomization (or spray-drying) to obtain a powder. This is then wet-granulated by impregnation with a coating agent, then covered with a protective coating agent and then dried.
[0052] Feed granulation
[0053] The enzyme particles and a nutritional base such as a mixture of wheat, soybean meal, extruded soybeans, palm oil, calcium carbonate, dicalcium phosphate, salt and a premix containing methionine, are mixed and heated to a temperature of 60 to 100°C, preferably chosen between 70 and 90°C. The mixture is then pelletized in a pelletizing press, the pellets obtained are cut to the desired length and then dried, to obtain the granulated feed.
[0054] Measurement of the xylanase activity of the food thus produced
[0055] After extraction of the enzyme contained in the granulated feed, the residual xylanase activity is measured according to the viscometry method. This method consists of incubating a solution containing the variant in the presence of wheat arabinoxylan at 30°C and determining the viscosity of the mixture using a microviscometer for 20 minutes. The xylanase activity corresponds to the degradation of arabinoxylan into oligoarabinoxylan and is proportional to the reduction in the viscosity of the substrate in the presence of the enzyme. Each measurement is carried out in duplicate.
[0056] The results are shown in [Fig.4]; they highlight the stability of the xylanase activity of the XYN321 protein compared to the reference XYN3 protein.
Claims
Claims
1. Thermostable protein expressing at least one xylanase activity, characterized in that it comprises or consists of a peptide sequence represented by SEQ ID NO: 1 comprising at least the mutations L34C and R38C.
2. Protein according to claim 1, characterized in that the peptide sequence SEQ ID NO: 1 comprises at least one mutation chosen from T1 12E, Q145E and S187R.
3. Protein according to claim 2, characterized in that the peptide sequence SEQ ID NO: 1 comprises at least the mutation Tl 12E.
4. Protein according to claim 3, characterized in that the peptide sequence SEQ ID NO: 1 comprises at least the mutation S187R.
5. Polynucleotide encoding a protein according to any one of claims 1 to 4.
6. Polynucleotide according to claim 5, characterized in that it comprises or consists of the nucleotide sequence SEQ ID NO: 2 having at each of positions 100-102 and 112-114, the codon TGT or TGC coding for cysteine.
7. Polynucleotide according to claim 6, characterized in that the nucleotide sequence SEQ ID NO: 2 further has at least any one of the following mutations, or any two of the mutations, or even the following three mutations: at position 334-336, the codon GAA or GAG coding for glutamic acid, at position 433-435, the codon GAA or GAG coding for glutamic acid, at position 559-561, the codon CGT, CGC, CGA, CGG, AGA, AGG coding for arginine.
8. An expression vector such as a plasmid comprising a polynucleotide according to any one of claims 5 to 7, and at least the elements necessary for its expression in a host cell.
9. A host cell comprising an expression vector according to claim Q
10. O. Zootechnical additive comprising at least one protein according to any one of claims 1 to 4.
11. Feed for animal nutrition comprising at least one zootechnical additive according to claim 10.
12. Use of at least one protein according to any one of claims 1 to 4, for feeding monogastric livestock, or for preparing a zootechnical additive according to claim 10 or a feed according to claim 11.
13. A method of producing a protein according to any one of claims 1 to 4, comprising at least one step of culturing a host cell according to claim 9 under conditions suitable for the production of said protein and a step of recovering said protein.
